Data / Form D filings / BioCytics, Inc.
BioCytics, Inc.: Form D filings
BioCytics, Inc., a biotechnology company in Huntersville, NC, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on March 13, 2026, reports $25,000 sold of a $7 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9801 KINCEY AVE. SUITE 145, Huntersville, NC, 28078
- Phone
- (704) 947-6599
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1971839
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | New notice | $7,000,000 | $25,000 | $6,975,000 | 1 | Jan 2, 2026 | sec.gov |
| Dec 28, 2023 | New notice | $4,000,000 | $25,000 | $3,975,000 | 1 | Dec 15, 2023 | sec.gov |
| Mar 31, 2023 | New notice | $8,000,000 | $1,355,000 | $6,645,000 | 18 | Feb 8, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Powderly | Executive Officer, Director | |
| Jim Powderly | Executive Officer |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Mar 9, 2026 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioCytics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.